Aeglea BioTherapeutics Inc. (AGLE) Gained 5.86% or 0.53 To Price $9.58 On Thursday


Aeglea BioTherapeutics Inc. (AGLE) gained 5.86% or 0.53 to $9.58. It is around 130705 shares traded, which is 68.87% compare to the average total volume 189797. The market cap of AGLE is $209.41 million. The year to date change is 74.07%. The 52 week price range is from $2.81 to $12.0. Price of AGLE have changed -1.84% during last week. It have changed -11.62% over last month, -8.40% over last 3 months, 50.08% over last 6 months and 173.41% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 9.84. It is 2.71% above current price. The 200-day Moving Averages for AGLE is 7.74. It is -19.21% below current price. The 52-week High is 12.0. It is 25.26% from the current price. The 52-week Low is 2.81. It is -70.67% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 2.61 on 2018-07-13. Short % to float is 4.28%. There are some statistics of AGLE. It is has market cap $209.41 million. The share outstanding is 21.86 million. The average volume is 189797. The revenue is 2.74M. The percent of top 15 Institution holding is 61.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -57.58%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -52.42%.


Tags:

Share this post